Hyperactivating EZH2 to augment H3K27me3 levels in regulatory T cells enhances immune suppression by driving early effector differentiation is a research paper published in Cell Reports (2024). On theSindex it has a DataRank of 0. It has been cited 25 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
ZonMw
Grant: 45219210
American Cancer Society
Grant: RSG-22-026-01
NIH
Grant: 1DP2CA247830-01
Engineering precision cancer immunotherapy
NIH
Grant: R35GM133434
NCI NIH HHS
Grant: DP2 CA247830
PEW Charitable Trusts
University of Colorado School of Medicine, Anschutz Medical Campus
Dutch Research Council (NWO)
Saint Baldricks Foundation
Alexander and Margaret Stewart Trust
Fields of Study
MeSH Terms
Keywords